tirzepatide news september 27 2025 In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL UPDATE ON WEIGHT LOSS MEDICATION
Description
Terra did an amazing job
Type 2 diabetes is the most common complication of obesity, affecting about 80% of overweight patients
Telehealth services like Doctronic.ai offer fast, accessible support if you have concerns about heart symptoms while on semaglutide
Cost : These meds can run up to $1000 - $1300 a month
